Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
The Lancet. Psychiatry|January 5, 2016
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trialR Hamish McAllister-Williams, Ian M Anderson, Andreas Finkelmeyer, et al.
Neuromodulation : Journal of the International Neuromodulation Society|April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's SyndromeJessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Bjpsych Open|February 15, 2019
Associations between childhood maltreatment and inflammatory markersAlish B Palmos, Stuart Watson, Tom Hughes, et al.
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
BMC Psychiatry|August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
BMC Psychiatry|July 6, 2021
Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)Lumbini Azim, Paul Hindmarch, Georgiana Browne, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Health Technology Assessment (Winchester, England)|June 2, 2025
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trialHamish McAllister-Williams, Nicola Goudie, Lumbini Azim, et al.
Pageof 19